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Abstract:  
Many microorganisms, as well as plants and fungi, synthesize thiamin, but vertebrates do not produce it. 
Phosphomethyl pyrimidine kinase is an enzyme involved in an intermediary step of thiamin biosynthesis from purine 
molecules. This enzyme is absent in humans.  Thus, it is a potential chemotherapeutic target for antileptospiral 
treatment.  Structure of this enzyme from Leptospira interrogans serovar lai strain 56601 has not yet been elucidated.  
We used the structural template of phosphomethyl pyrimidine kinase from Thermus thermophilus HB8 for modeling 
the phosphomethyl pyrimidine kinase structure from Leptospira interrogans serovar lai strain 56601.  The model is 
deposited in Protein Data Bank (PDB ID: 2G53) at RCSB.  Thus, we analyse and propose the usefulness of the 
modeled phosphomethyl pyrimidine kinase for the design of suitable inhibitors towards the treatment of leptospirosis.   
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Background: 
Leptospirosis is a zoonotic disease caused by infection with 
pathogenic Leptospira species.  It is currently identified as 
a worldwide emerging infectious disease, especially in 
developing countries.  Leptospirosis caused by Leptospira 
interrogans serovar lai strain 56601 is commonly 
prevalent in India, China, Japan, Malaysia and Singapore. 
These spirochaetes are transmitted to man usually either by 
direct or indirect contact with the urine of the infected 
animal.  The clinical presentation of the disease is biphasic, 
with the acute or septicemic phase lasting about a week, 
followed by immune phase, characterized by antibody 
production and excretion of leptospires in urine. [1] 
Infection may be sub clinical, mild or severe, affecting 
various internal organs. Febrile illness of sudden onset, 
chills, myalgia and abdominal pain are the common 
symptoms in sub clinical or mild infections. Jaundice and 
acute renal failure are also seen in severe cases [1]. Specific 
antibiotic treatment using doxycycline or penicillin 
antibiotics has shown mixed results for mild or sub clinical 
infections.  Treatment of severe leptospirosis (organism 
localized in tissues) is still unclear. [1] Availability of 
complete genome sequence of Leptospira interrogans 
serovar lai strain 56601 [2] has opened great opportunities 
for identifying potential drug targets by computational 
analysis.  This can in turn improve leptospiral treatments.  
 
Vitamin B1, in its active form thiamin pyrophosphate, is an 
essential cofactor for several important enzymes in 
carbohydrate metabolism.  Many microorganisms, as well 
as plants and fungi, synthesize thiamin, but vertebrates do 
not produce it.  In bacteria, it is synthesized by coupling of 
pyrimidine (hydroxymethyl pyrimidine; HMP) and thiazole 
(hydroxyethyl thiazole) moieties. Of the many enzymes 
involved in bacterial cell’s thiamin biosynthetic pathway, 
phosphomethyl pyrimidine kinase plays a key role.   
Hence, it is a promising chemotherapeutic target. This 
is also known as HMP phosphokinase and it catalyses 
the conversion of 4-amino 2-methyl 5-phosphomethyl 
pyrimidine to 4-amino 2-methyl 5-hydroxymethyl 
pyrimidine diphosphate, an intermediary step in the 
conversion of purine into thiamine. [9] This enzyme is 
coded by thiD gene (822 bp in length) located on 
chromosome 1 of Leptospira interrogans serovar lai 
strain 56601. [2, 3]   Here, we predict 3 Dimensional 
structure of Leptospira interrogans serovar lai strain 
56601 phosphomethyl pyrimidine kinase employing 
homology modeling. The predicted 3D structure was 
further subjected to structural feauture analysis, 
aiming towards developing potent inhibitors. 
 
Methodology: 
The protein sequence (273 residues long) was 
obtained from the SWISS PROT database (Q8F9R1). 
The protein databank (PDB) contains two 
phosphomethyl pyrimidine kinase structures from 2 
species (Salmonella tyhpimurium (PDB ID: 1JXH), 
Thermus thermophilus HB8 (PDB ID: 1UB0)). [4] 
However, structure for phosphomethyl pyrimidine 
kinase from Leptospira interrogans serovar lai strain 
56601 was not available.  Sequence analysis using 
BLASTP  [5] against PDB sequences showed 
phosphomethyl pyrimidine kinase from Leptospira 
interrogans serovar lai strain 56601 having 38% 
sequence identity (highest homology compared to 
other known structures) with Thermus thermophilus 
HB8.  Therefore we used the structure of Thermus 
thermophilus HB8 phosphomethyl pyrimidine kinase 
(PDB: 1UB0) as template for building homology 
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56601 phosphomethyl pyrimidine kinase using 
MODELLER [6] by satisfaction of spatial restraints.   
MALIGN script of MODELLER was implemented to build 
global alignment in this modeling process. The 
obtained alignment is shown in Figure 1. 
 
 
Figure 1: Output of MALIGN script showing the alignment and ATP/GTP binding site (in yellow color) 
 
 
Figure 2: Displaying the ATP/GTP binding site (yellow color) in phosphomethyl pyrimidine kinase enzyme from 
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The backbone of the obtained model overlapped well 
with the template structure and the most reliable 
structure was chosen based on least objective function 
value and stereo chemical quality of the models using the 
PROCHECK analysis. [7] In addition, the 
superimposition was also performed using the 
SUPERPOSE command in MODELLER and the RMSD 
(root mean square deviation) between predicted model 
and template was 0.4 angstrom. The predicted model 
quality assessment was checked using Ramachandran 
plot analysis for phi and psi torsion angles. The analysis 
shows that 90.4% of residues are found to be in the 
allowed region of the plot, which is more than the 
average cut-off of 90% in most reliable models. [8] The 
final model has been deposited in PDB and is now 
publicly accessible [PDB ID: 2G53]. The protein 
structure predicted is displayed in figure 2. 
 
Results and Discussion: 
An active phosphomethyl pyrimidine kinase is a 273 
residue long monomer with a molecular mass of 29 kDa. 
A similar result has been documented earlier in E.coli 
ThiD protein. [10] The protein molecule is an alpha beta 
structure identified to contain a single large domain (17-
270 residues).  Totally 8 helices and 10 sheets are 
present in it.   All helices and sheets are right hand 
twisted.  All sheets are arranged parallel to each other 
except for β4 and β9 sheets, which are anti parallel.   
 
In E.coli, although the phosphorylation reaction of HMP 
appears to occur by two steps, only one ATP binding 
motif was found in its ThiD. It is a two step mechanism 
for phosphorylation is still unclear. [11] In the current 
work, only a single large domain has been identified.   
Possibly the phosphorylation process in Leptospira 
species also follows the not so well understood two step 
mechanism.  Walker et al (1984) suggested that many 
ATP- and GTP-binding proteins contain a consensus 
sequence motif [AG]X%GK[ST]. A sequence similar to 
this motif, GGGAGIQADLKT, is found in the ThiD 
sequence starting at position 19 from the N terminus. 
Previously a similar sequence motif was also reported in 
E.coli.  [10] This indicates the domain identified in 
phosphomethyl pyrimidine kinase could be an ATP 
binding motif.          
 
Conclusion: 
Doxycycline or penicillin drugs are commonly used for 
treatment of mild or subclinical leptospiral infections. 
Treatment for severe leptospiral disease is still unclear.  
Therefore, it is important to design effective 
antileptospiral drugs. A molecular model of the 
phosphomethyl pyrimidine kinase from Leptospira 
interrogans serovar lai strain 56601 is documented in 
this study. The predicted model is believed to provide 
valuable insights towards the inhibitor design of 
Phosphomethyl pyrimidine kinase pertaining to 
leptospirosis treatment. 
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